4.26
price up icon0.71%   0.03
after-market Dopo l'orario di chiusura: 4.05 -0.21 -4.93%
loading
Precedente Chiudi:
$4.23
Aprire:
$4.15
Volume 24 ore:
170.35K
Relative Volume:
1.20
Capitalizzazione di mercato:
$45.94M
Reddito:
-
Utile/perdita netta:
$-19.09M
Rapporto P/E:
-2.3933
EPS:
-1.78
Flusso di cassa netto:
$-17.24M
1 W Prestazione:
-0.47%
1M Prestazione:
+32.71%
6M Prestazione:
-21.11%
1 anno Prestazione:
-3.62%
Intervallo 1D:
Value
$4.00
$4.41
Intervallo di 1 settimana:
Value
$3.55
$4.41
Portata 52W:
Value
$2.55
$6.118

Lantern Pharma Inc Stock (LTRN) Company Profile

Name
Nome
Lantern Pharma Inc
Name
Telefono
972-277-1136
Name
Indirizzo
1920 MCKINNEY AVENUE, DALLAS, TX
Name
Dipendente
24
Name
Cinguettio
@lanternpharma
Name
Prossima data di guadagno
2025-03-21
Name
Ultimi documenti SEC
Name
LTRN's Discussions on Twitter

Confronta LTRN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LTRN
Lantern Pharma Inc
4.26 43.46M 0 -19.09M -17.24M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-10-07 Iniziato H.C. Wainwright Buy

Lantern Pharma Inc Borsa (LTRN) Ultime notizie

pulisher
Jul 24, 2025

Why Lantern Pharma Inc. stock is on top investor watchlistsOverwhelming financial success - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Will Lantern Pharma Inc. stock benefit from interest rate changesExplosive portfolio gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Lantern Pharma Inc. Stock Analysis and ForecastBreakthrough stock performance - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Lantern Pharma Inc. stock priceTremendous gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Lantern Pharma (NASDAQ: LTRN) Reports First Complete Response in Phase 1 LP-284 Trial for Aggressive DLBCL - Barchart.com

Jul 23, 2025
pulisher
Jul 23, 2025

Lantern Pharma reports complete response in aggressive lymphoma patient - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Lantern Pharma Reports Complete Response in Heavily Pre-Treated Lymphoma Patient with LP-284 in Phase 1 Clinical Trial - Business Wire

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Lantern Pharma Inc. stockTremendous gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Lantern Pharma Inc. a good long term investmentTriple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Lantern Pharma (NASDAQ: LTRN) Secures EU Patent For AI-Designed Cancer Drug LP-284 - Barchart.com

Jul 22, 2025
pulisher
Jul 21, 2025

Lantern Pharma (LTRN) Secures EU Patent for Cancer Drug LP-284 - GuruFocus

Jul 21, 2025
pulisher
Jul 21, 2025

Lantern Pharma secures EU patent for AI-driven cancer drug LP-284 - MSN

Jul 21, 2025
pulisher
Jul 21, 2025

Lantern Pharma Secures EU Patent Allowance for LP-284, Bolstering Global IP Position for AI-Developed Cancer Therapy - BioSpace

Jul 21, 2025
pulisher
Jul 21, 2025

Lantern Pharma (LTRN) Gains Patent Approval for Key Drug in Euro - GuruFocus

Jul 21, 2025
pulisher
Jul 17, 2025

Lantern Pharma Unveils AI Module for Predicting Cancer Treatment Efficacy - AInvest

Jul 17, 2025
pulisher
Jul 16, 2025

Lantern Pharma (NASDAQ: LTRN) Launches AI Module to Accelerate Development of Targeted Cancer Combination Therapies - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

IBN Initiates Coverage of Lantern Pharma Inc. - GlobeNewswire

Jul 16, 2025
pulisher
Jul 16, 2025

Lantern Pharma Initiates Coverage with IBN, Aims to Revolutionize Oncology Drug Development - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Why Lantern Pharma Inc. stock attracts strong analyst attentionFree Stock Movement Tracking - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Lantern Pharma Inc. stock performs during market volatilityInvestor Friendly Risk Reward - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Lantern Pharma Inc. Unveils AI-Powered Module to Predict Activity and Efficacy of Combination Regimens in Clinical Cancer Treatment - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Lantern Pharma launches AI module to predict cancer treatment combos - Investing.com India

Jul 15, 2025
pulisher
Jul 15, 2025

Lantern Pharma (LTRN) Launches AI Module for Cancer Treatment Ad - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Lantern Pharma launches AI module to predict cancer treatment combos By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Lantern Pharma Unveils Groundbreaking AI-Powered Module to Predict Activity and Efficacy of Combination Regimens in Clinical Cancer Treatment - Business Wire

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Lantern Pharma Inc. stock price move sharplyFree Access to Community - Newser

Jul 15, 2025

Lantern Pharma Inc Azioni (LTRN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):